Cline receives clearance for ex-vivo testing of StemCART product on human cartilage tissue
Cline Scientific AB has received clearance from the Swedish Ethical Review Authority for the collection and testing of human cartilage tissue as part of the StemCART project.This enables the start of ex-vivo tests to evaluate Cline's unique cells and their ability to repair cartilage. Cline can now, through its collaborating clinicians, collect samples of routinely discarded material from participating patients who are undergoing joint surgery. The study will start immediately and is expected to continue through Q2 of 2022. It is an important validation step for StemCART. For the